
IGC secures EMBO Installation Grant
IGC researcher Marco Fumasoni has been awarded an EMBO Installation Grant in the 2022 edition.
IGC researcher Marco Fumasoni has been awarded an EMBO Installation Grant in the 2022 edition.
Research led by the Innate Immunity and Inflammation lab at the IGC reveals how anthracyclines limit inflammation, positioning them as potential treatments for sepsis.